Clinical trials central testing

Peter Mac offers clinical trial central testing to a range of international and local pharmaceutical and diagnostic companies, CROs and research organisations including hospitals and universities.

Our laboratories are NATA accredited and are experienced in a range of testing techniques, logistics management, project management, quality control and documentation required for clinical trials.

Why Peter Mac?

The Centre for Clinical Cancer Genomics provides capabilities in clinical care, research and clinical testing ensure that the highest level of testing is available. We are able to meet delivery deadlines and provide the appropriate level of support and management for clinical trials testing.

Services

Clinical trial testing including:

  • germline
  • somatic
  • haematology
  • custom assays
  • support for data analytics.

Peter Mac participates in trials for new diagnostic instrumentation and is available to perform safety monitoring testing and other pathology test for clinical trials where required.

Example of services available

TypeTesting availableExample tests
Germline

Next Gen Sequencing

PCR

BRCA1 & 2, Ashkenazi

MLH1, MSH2, MSH6, PMS2

Somatic

FISH

Next Gen Sequencing

MET

Immunohistochemistry

EGFR

KRAS

NRAS

TP53

HER2

Haematology

CLL

Data Analytics

Peter Mac can review NGS output with PathOS: a decision support application for the analysis and reporting of NGS data

Related Experts

Stephen Fox, Director of Pathology

CONTACT

Clinical Trials Business Development Manager